Previous close | 61.00 |
Open | 61.00 |
Bid | 61.00 x 60000 |
Ask | 62.00 x 60000 |
Day's range | 61.00 - 61.00 |
52-week range | 45.80 - 63.00 |
Volume | |
Avg. volume | 4 |
Market cap | 8.242B |
Beta (5Y monthly) | 0.92 |
PE ratio (TTM) | N/A |
EPS (TTM) | -1.75 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | 0.55 (0.90%) |
Ex-dividend date | 17 Jun 2024 |
1y target est | 46.22 |
KBR (NYSE: KBR) announced today it has been selected as one of 11 awardees for a multiple-award, indefinite-delivery/indefinite-quantity contract by the Defense Health Agency to provide health and wellness support for military personnel and their families. KBR will have the opportunity to bid on task orders under the Medical Q Coded Support and Services Next Generation (MQS2-NG) contract, which contains a ceiling of $43 billion.
KBR (NYSE: KBR) and Sumitomo Chemical announced today that they have signed an alliance agreement to make KBR an exclusive licensing partner for Sumitomo Chemical's state-of-the-art propylene oxide by cumene (POC) technology. Propylene oxide is an intermediate product used primarily in the further manufacture of polyurethanes. Polyurethane is used in many products such as foams, coatings, adhesives and sealants which serve growing industries such as construction, industrials and automotive.
KBR (NYSE: KBR) announced today that its Board of Directors has declared a regular quarterly dividend of $0.15 per share on the company's common stock, par value $0.001 per share, to be paid on July 15, 2024, to stockholders of record on June 17, 2024.